Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Therapy of peritoneally disseminated colon cancer by TAP-deficient embryonic stem cell-derived macrophages in allogeneic recipients.

Haga E, Endo Y, Haruta M, Koba C, Matsumura K, Takamatsu K, Ikeda T, Nishimura Y, Senju S.

J Immunol. 2014 Aug 15;193(4):2024-33. doi: 10.4049/jimmunol.1303473. Epub 2014 Jul 16.

2.

Application of iPS cell-derived macrophages to cancer therapy.

Senju S, Koba C, Haruta M, Matsunaga Y, Matsumura K, Haga E, Sasaki Y, Ikeda T, Takamatsu K, Nishimura Y.

Oncoimmunology. 2014 Jan 1;3(1):e27927. Epub 2014 Feb 14.

3.

Determination of Candida species nestled in denture fissures.

Koba C, Koga C, Cho T, Kusukawa J.

Biomed Rep. 2013 Jul;1(4):529-533. Epub 2013 May 22.

4.

Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft models.

Koba C, Haruta M, Matsunaga Y, Matsumura K, Haga E, Sasaki Y, Ikeda T, Takamatsu K, Nishimura Y, Senju S.

PLoS One. 2013 Jun 24;8(6):e67567. doi: 10.1371/journal.pone.0067567. Print 2013.

5.

TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells.

Haruta M, Tomita Y, Yuno A, Matsumura K, Ikeda T, Takamatsu K, Haga E, Koba C, Nishimura Y, Senju S.

Gene Ther. 2013 May;20(5):504-13. doi: 10.1038/gt.2012.59. Epub 2012 Aug 9.

PMID:
22875043
6.

Supplemental Content

Support Center